Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
Agha-Hosseini, M 1; Kashani, L 2; Aleyaseen, A 1; Ghoreishi, A 3; Rahmanpour, H 4; Zarrinara, AR 5; Akhondzadeh, S 6,1
[Miscellaneous Article] BJOG: An International Journal of Obstetrics & Gynaecology. 115(4):515-519, March 2008.

(Format: HTML, PDF)

Objective: The aim of this double-blind and placebo-controlled trial was to investigate whether saffron (stigma of Crocus sativus L.) could relieve symptoms of premenstrual syndrome (PMS).

Design: Double-blind, randomised and placebo-controlled trial.

Setting: Departments of Gynaecology/Obstetrics and Psychiatry, Tehran and Zanjan University of Medical Sciences.

Population: Women aged 20-45 years with regular menstrual cycles and experience of PMS symptoms for at least 6 months were eligible for the study.

Method: Women were randomly assigned to receive capsule saffron 30 mg/day (15 mg twice a day; morning and evening) (group A) or capsule placebo (twice a day) for a two menstrual cycles (cycles 3 and 4).

Main outcome measures: The primary outcome measure was the Daily Symptom Report, and secondary outcome measure was the Hamilton Depression Rating Scale.

Results: In this trial, saffron was found to be effective in relieving symptoms of PMS. A significant difference was observed in efficacy of saffron in cycles 3 and 4 in the Total Premenstrual Daily Symptoms and Hamilton Depression Rating Scale.

Conclusion: The results of this study indicate the efficacy of C. sativus L. in the treatment of PMS. However, a tolerable adverse effects profile of saffron may well confirm the application of saffron as an alternative treatment for PMS. These results deserved further investigations.

Copyright (C) 2008 Blackwell Publishing Ltd.